Psychiatric Drugs

Researchers report the cumulative effects of major biases on the apparent efficacy of antidepressant and psychotherapy treatments.

Disturbingly, our study and others reveal that the black box warning is now ignored in many countries, since antidepressant prescriptions for children are on the rise again. Despite increasing certainty that antidepressants are ineffective and likely cause suicidal behavior in young people, psychiatry continues to claim that they reduce suicide risk.

A new study examines the extent to which patterns in prescription drug misuse and substance use disorder symptoms can be predicted by education level

Researchers point to the risks of using antipsychotics with youth and caution against the practice.

Increased frequency of digital media use can increase symptoms of ADHD among adolescents, study finds.

People who reduced antipsychotic use by tapering were doing just as well after five years as those who continued using the drugs.

Researchers find that valproate decreases brain volume in a region associated with emotion processing across all participants.

New research has found that a childhood ADHD diagnosis is not predictive of adult functioning in boys.

New intervention shows promise in reducing over-prescription of off-label antipsychotics in older adults.

During the past twenty years, the American Foundation for Suicide Prevention and American psychiatry have adopted a "medicalized" approach to preventing suicide, claiming that antidepressants are protective against suicide. Yet, the suicide rate in the United States has increased 30% since 2000, a time of rising usage of antidepressants. A review of studies of the effects of mental health treatment and antidepressants on suicide reveals why this medicalized approach has not only failed, but pushed suicide rates higher.

Research investigates clinicians’ perspectives on best care practices and the complicated realities of providing care in the face of agency limitations and mechanized interventions.

Study of students without an ADHD diagnosis finds that stimulants (Adderall) have little impact on cognitive performance.

Three out of four users of the sedative, zolpidem (brand name Ambien), do not follow FDA recommendations to reduce risk.

Ironically, my post-traumatic stress disorder no longer stems from the events that led to my hospitalizations, but from the maltreatment I received within the hospitals. Now, every time I take my medication late or miss a dose, I feel the unsettling presence of dissociation creeping in, the terrifying panic of losing my mental bearings and being rehospitalized. 

Study finds that reduced cortical thickness and brain surface area associated with 'schizophrenia' may result from antipsychotic drug use.

As a service user of the REST project at Mind in Camden, I want to celebrate World Benzodiazepine Day 2018 by telling the world a little bit about what REST has done for me. I’m now 18 months off benzos, but I still attend REST regularly to process the anger and grief I feel about what I went through, and to support those who are still tapering.

Study details Medicaid-insured birth cohort’s exposure to psychiatric medications and mental health services.

A new study in JAMA Psychiatry found that transcranial magnetic stimulation was no better than placebo for treatment-resistant depression.

Members of the U.S. Food and Drug Administration’s Psychiatry Products division go on the defensive in a new article, responding to concerns about the agency’s approval of digital aripiprazole.

Researchers take action after study exposes enduring sexual dysfunction as a potential side effect of serotonin reuptake inhibiting antidepressants, 5α-reductase inhibitors, and isotretinoin.

The BMJ’s clinical editor takes issue with uncritical media coverage of antidepressant network meta-analysis, outlining reporting missteps.

A new study finds that stimulant prescribing rates to children continue to rise despite the well-established evidence documenting overdiagnosis of ADHD and overprescription of stimulants.

The most important data in an RCT is not whether the drug provides a statistically significant benefit over placebo. The most important data is the “number needed to treat” calculation (NNT). For the person considering taking an antidepressant or an antipsychotic, the NNT data provides the “math” needed to weigh the potential benefit of taking the drug against the potential harm of doing so.

A new study, published in Acta Psychiatrica Scandinavica, found that antidepressant efficacy was not dependent on severity.

Effects of discontinuing SSRIs and SNRIs reported on an online forum indicate significant and long-lasting withdrawal symptoms.